Tumor Intiltrating Lymphocytes (TIL) – VHIO clinical trials

A phase 2, Multicenter Study of TILs Treatment in Germ Cell tumors: the ARES Study

This study is looking at a new treatment for certain types of advanced germ cell tumours that haven't responded to standard chemotherapy. It uses a type of immunotherapy where a patient's own immune cells are specially treated to fight the cancer, combined with other medicines.